Martin T. Schechter

发表

“As long as that place stays open, I’ll stay alive”: Accessing injectable opioid agonist treatment during dual public health crises

Kaitlyn Jaffe, Scott Harrison, E. Oviedo-Joekes, 2023, Harm Reduction Journal.

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).

N. Bansback, Heather Palis, Kirsten Marchand, 2022, The International journal on drug policy.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, The International journal on drug policy.

Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, BMC Health Services Research.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, The International journal on drug policy.

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, Addictive behaviors reports.

Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, International Journal of Drug Policy.

The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and action.

J. Foreman, Scott Harrison, E. Oviedo-Joekes, 2023, Journal of substance use and addiction treatment.

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

Scott Harrison, E. Oviedo-Joekes, Scott MacDonald, 2023, Substance Abuse Treatment, Prevention, and Policy.

How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives

N. Bansback, Scott Harrison, E. Oviedo-Joekes, 2023, Drugs: Education, Prevention and Policy.

The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.

A. Anis, D. Guh, E. Oviedo-Joekes, 2010, Drug and alcohol dependence.